Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
3.1. Market Snippet by Product Type
3.2. Market Snippet by Route of Administration
3.3. Market Snippet by Diseases
3.4. Market Snippet by End User
3.5. DataM CLO Scenario
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing prevalence of infectious and zoonotic diseases.
4.1.1.2. Increasing use of Adjuvants in vaccine
4.1.2. Restraints
4.1.2.1. High costs of research
4.1.2.2. Stringent regulatory policies
4.1.3. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Pricing Analysis
5.5. Design Advances
5.6. Key Companies to Watch
5.7. Epidemiology
6. By Product Type
6.1. Introduction
6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
6.3. Market Attractiveness Index, By Product Type
6.3.1. Adjuvant Emulsions
6.3.2. Introduction
6.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%)
6.4. Pathogen Components
6.5. Particulate Adjuvants
6.6. Combination Adjuvants
6.7. Others
7. By Route of Administration
7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
7.3. Market Attractiveness Index, By Route of Administration
7.4. Oral
7.4.1. Introduction
7.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
7.5. Intramuscular
7.6. Intranasal
7.7. Subcutaneous
7.8. Intradermal
7.9. Others
8. By Diseases
8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diseases
8.3. Market Attractiveness Index, By Diseases
8.4. Cancer
8.4.1. Introduction
8.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
8.5. Infectious diseases
9. By End User
9.1. Introduction
9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
9.3. Market Attractiveness Index, By End User
9.4. Pharmaceutical companies
9.4.1. Introduction
9.4.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
9.5. Research Institutes
9.6. Others
10. By Region
10.1. Introduction
10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
10.3. Market Attractiveness Index, By Region
10.4. North America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diseases
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. The U.S.
10.4.7.2. Canada
10.4.7.3. Mexico
10.5. Europe
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diseases
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. Germany
10.5.7.2. The U.K.
10.5.7.3. France
10.5.7.4. Italy
10.5.7.5. Spain
10.5.7.6. Rest of Europe
10.6. South America
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diseases
10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
10.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.6.7.1. Brazil
10.6.7.2. Argentina
10.6.7.3. Rest of South America
10.7. Asia-Pacific
10.7.1. Introduction
10.7.2. Key Region-Specific Dynamics
10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diseases
10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
10.7.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.7.7.1. China
10.7.7.2. India
10.7.7.3. Japan
10.7.7.4. Australia
10.7.7.5. Rest of Asia Pacific
10.8. The Middle East and Africa
10.8.1. Introduction
10.8.2. Key Region-Specific Dynamics
10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Route of Administration.
10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diseases
10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Competitor Vaccine Adjuvants Strategy Analysis
11.3. Comparative Drug Portfolio Analysis
11.4. Market Positioning/Share Analysis
11.5. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. InvivoGen
12.1.1. Company Overview
12.1.2. Drug Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. OZ Biosciences
12.3. Sigma-Aldrich Co. LLC
12.4. SEPPIC
12.5. SPI Pharma
12.6. Agenus, Inc
12.7. Aphios Corp
12.8. VaLiant LLC
12.9. Vaxine Pty Ltd
12.10. Kineta, Inc
13. Premium Insights
14. DataM Intelligence
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us